Fielder Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,528
Closed -$243K 304
2025
Q4
$243K Sell
2,528
-419
-14% -$40.7K 0.05% 235
2025
Q3
$281K Buy
+2,947
New +$271K 0.06% 185
2024
Q4
Sell
-2,506
Closed -$226K 225
2024
Q3
$226K Sell
2,506
-150
-6% -$12.6K 0.07% 179
2024
Q2
$209K Sell
2,656
-56
-2% -$4.59K 0.08% 178
2024
Q1
$236K Sell
2,712
-19
-0.7% -$1.62K 0.11% 135
2023
Q4
$225K Buy
+2,731
New +$208K 0.14% 123

Other funds holding MDT

Fielder Capital Group's MDT Position: Q1 2026 in Review

Fielder Capital Group sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,528 shares — an estimated $243K sold.

Fielder Capital Group first reported a position in MDT in Q4 2023 and held it in 6 quarters. The position peaked at $281K in Q3 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Fielder Capital Group reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Fielder Capital Group sold 2,528 Medtronic shares in Q1 2026, an estimated $243K.
  • Fielder Capital Group first reported a position in Medtronic in Q4 2023 and held it in 6 quarters.
  • Fielder Capital Group's Medtronic position peaked at $281K in Q3 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.